吉林男性得了前列腺炎该怎么办(吉林治疗早泄在哪个医院才好) (今日更新中)

SAN FRANCISCO, March 23 (Xinhua) -- Yahoo Inc. on Wednesday introduced a new feature to its search engine, which the company said can deliver answers and direct access to websites before users complete their query or hit the search button.The new feature, called Search Direct, predicts search results as fast as a person types and presents those results dynamically, Yahoo said."With today's launch, direct answers -- not the search results page -- is the primary focus. We are redefining the search process and prominently displaying direct answers where search decisions are being made," Shashi Seth, Yahoo's senior vice president of search and marketplaces, said in a statement."Search Direct is evidence of Yahoo continuing to lead innovation in search, enabling people to take action faster, find what is most important, and sample what is possible with the next stage of search technology," he added.Yahoo announced that Search Direct is rolling out in a public test version to its users across the United States Wednesday, and will be available in other Yahoo products and markets later this year.

BEIJING, March 3 (Xinhuanet) -- A new study suggested that regular use of painkiller ibuprofen may cut the risk of developing Parkinson's disease, according to Reuters reports.The research findings were published in the online edition of the journal Neurology on Wednesday and later will appear in the print edition on March 8.The study, which followed more than 136,000 U.S. men and women for six years, showed that people who took ibuprofen at least twice a week were 38 percent less likely to develop Parkinson's, a brain disorder that causes tremors and movement problems, compared to those who didn't take the pain reliever so often.Ibuprofen is sold in the U.S. as a non-steroidal anti-inflammatory drug (NSAID). But the study didn't prove that other NSAIDS, like aspirin or naproxen, could also cut the Parkinson's risk."Our study suggests ibuprofen could be a potential neuroprotective agent against Parkinson's," says lead researcher Dr. Xiang Gao from Harvard Medical School, "Protective effects are seen after taking ibuprofen two or more times a week. That's so-called regular use."However, he also warned that no proof has been found that ibuprofen itself can help ward off Parkinson's, and said that it's too early to recommend people to start taking ibuprofen to protect against the disorder.Gao said, "We just see an association, not some causal relationship."Besides, regular ibuprofen use has risks, like stomach bleeding and kidney damage.

BEIJING, April 24 (Xinhua) -- The Chinese government has ordered food companies to keep clear and intact records of all their production and selling operations as part of the efforts to prevent the illegal use of food additives.All food manufacturing and management companies must examine all products in stock for any trace of illegal food additives and keep records of the results in accordance with laws and regulations, according to a circular released Sunday by the food safety committee under the State Council, or China's Cabinet.The circular came days after Vice Premier Li Keqiang warned of the great harm from illegal additives in food, promising "a firm attitude, iron-hand measures and more efforts" in dealing with the problem.Companies that fail to keep genuine and intact records and documents will be ordered to reform, and those providing fake records and certificates will be suspended from operations and punished accordingly, said the circular.According to the circular, it is strictly forbidden to produce and sell non-edible materials that are likely to be used in food production without official certificates, and authorized production companies of these materials must adopt a real-name selling system.These materials, including those banned in animal feed and drinking water, should not be sold to food and feed companies, the circular added.A series of food safety scandals emerged in China recently. In one of the latest cases, steamed buns in Shanghai were reported, last week, to have been dyed, sold past their expiration date, or laced with coloring additives to mislead consumers.

WASHINGTON, March 24 (Xinhua) -- The U.S. Food and Drug Administration (FDA) on Thursday approved the use of Zostavax, a live attenuated virus vaccine, for the prevention of shingles in individuals 50 to 59 years of age. Zostavax is already approved for use in individuals 60 years of age and older.In the United States shingles affects approximately 200,000 healthy people between the ages of 50 and 59, per year. It is a disease caused by the varicella-zoster virus, which is a virus in the herpes family and the same virus that causes chickenpox.After an attack of chickenpox, the virus lies dormant in certain nerves in the body. For reasons that are not fully understood, the virus can reappear in the form of shingles, more commonly in people with weakened immune systems and with aging."The likelihood of shingles increases with age. The availability of Zostavax to a younger age group provides an additional opportunity to prevent this often painful and debilitating disease" said Karen Midthun, director of FDA's Center for Biologics Evaluation and Research, in a statement. ( Shingles is characterized by a rash of blisters, which generally develop in a band on one side of the body and can cause severe pain that may last for weeks, and in some people, for months or years after the episode.Approval was based on a multicenter study conducted in the United States and four other countries in approximately 22,000 people who were 50-59 years of age. Half received Zostavax and half received a placebo. Study participants were then monitored for at least one year to see if they developed shingles. Compared with placebo, Zostavax reduced the risk of developing shingles by approximately 70 percent.The most common side effects observed in the study were redness, pain and swelling at the site of injection, and headache, according to the FDA.Zostavax, manufactured by Merck & Co., was originally approved on May 26, 2006, for the prevention of shingles in individuals 60 years of age and older.

WASHINGTON, May 3 (Xinhua) -- People diagnosed with asthma in the United States grew by 4.3 million between 2001 and 2009, according to a new report released Tuesday by the Centers for Disease Control and Prevention (CDC).In 2009, nearly one in 12 Americans were diagnosed with asthma. In addition to increased diagnoses, asthma costs grew from about 53 billion U.S. dollars in 2002 to about 56 billion dollars in 2007, about a six percent increase. The explanation for the growth in asthma rates is unknown, according to the CDC.Asthma is a lifelong disease that causes wheezing, breathlessness, chest tightness, and coughing, though people with asthma can control symptoms and prevent asthma attacks by avoiding things that can set off an asthma attacks, and correctly using prescribed medicine, like inhaled corticosteroids. The report highlights the benefits of essential asthma education and services that reduce the impact of these triggers, but most often these benefits are not covered by health insurers."Despite the fact that outdoor air quality has improved, we've reduced two common asthma triggers -- secondhand smoke and smoking in general -- asthma is increasing," said Paul Garbe, chief of CDC 's Air Pollution and Respiratory Health Branch. "While we don't know the cause of the increase, our top priority is getting people to manage their symptoms better."Asthma triggers are usually environmental and can be found at school, work, home, outdoors, and elsewhere and can include tobacco smoke, mold, outdoor air pollution, and infections linked to influenza, cold-like symptoms, and other viruses.According to the report, asthma diagnoses increased among all demographic groups between 2001 and 2009, though a higher percentage of children reported having asthma than adults (9.6 percent compared to 7.7 percent in 2009). Annual asthma costs in the United States were 3,300 dollars per person with asthma from 2002 to 2007 in medical expenses. About two in five uninsured and one in nine insured people with asthma could not afford their prescription medication."Asthma is a serious, lifelong disease that unfortunately kills thousands of people each year and adds billions to our nation's health care costs," said CDC Director Thomas Frieden. "We have to do a better job educating people about managing their symptoms and how to correctly use medicines to control asthma so they can live longer more productive lives while saving health care costs."

来源：资阳报